Background: Central Council for Research in Ayurvedic Sciences (CCRAS) is actively involved in the scientific process of drug development adopting prevalent guidelines such as good clinical practices guidelines for Ayurveda, Siddha, Unani (ASU) drugs (GCP-ASU), Ministry of AYUSH and National ethical guidelines for Bio-medical Research (ICMR), WHO guidelines for traditional medicines, etc.
INTRODUCTION
The research activities of Central Council for Research in Ayurvedic Sciences are carried out through its 30 institutes/centers/units located all over India (each institute is assigned with a particular mandate for research) and also through collaborative studies with various universities, hospitals, and institutes. These include clinical research, medicinal plant research, drug standardization, pharmacological research, and literary research and documentation.
1 Biodiversity of natural resources has served not only for the primary human needs but also for healthcare, since time immemorial. The Indian subcontinent, with the history of one of the oldest civilization, harbors many traditional healthcare systems. Their development was supported by the diverse biodiversity in flora and fauna due to variations in geographical landscaping. Besides Ayurveda, other traditional and folklore systems of health care were developed in the different time periods in the Indian subcontinent, where more than 7500 plant species were used. Hence there is a certain need that these health practices and vast traditional knowledge of various plants in the treatment of disease may be explored with the modern scientific approaches and can be used for bringing out these drugs after proper validation of their safety and efficacy through systemic process of drug development for betterment of the mankind. Diabetes CCRAS has successfully developed a drug AYUSH 82 for the management of type 2 diabetes. It was developed after series of safety toxicity studies which have shown no toxic sign even at 10 times of intended therapeutic dose. The drug has shown a statistically significant reduction in fasting and postprandial blood sugar level along with clinical improvement in diabetes mellitus without any adverse effect. The drug is available in the market.
Malaria
Malaria is still one of the major national health problems. CCRAS has developed an antimalarial drug AYUSH-64 through extensive pharmacological, toxicological and clinical studies. It has been patented by the council through National Research and Development Corporation, New Delhi (Patent No. 152863). The study was done in collaboration with the National Malaria Eradication program (Govt. of Haryana and Tamil Nadu) with 72-90% clinical improvement. The response of treatment in the double-blind controlled study with chloroquine and primaquine as an active control, AYUSH-64 have shown 89 to 95% of improvement without any side effect. The drug is available in the market. Also 17 Ayurvedic formulations for reproductive and child health (RCH) care, program have been developed viz. AYUSH AG tablet, AYUSH GG tablet, AYUSH PG tablet, AYUSH ADE candy, AYUSH BL oil, AYUSH SDM tablet, AYUSH PK avaleha, AYUSH SS granules, AYUSH BR leham, AYUSH BR tablet, AYUSH BC tablet, AYUSH AP (Ark Pudina), AYUSH KVM syrup, AYUSH VRG tablet, AYUSH LND tablet, AYUSH UT ointment and AYUSH KD powder. Apart from these Bal RasayanPreparation for general resistance in children, AYUSH Ghutti-Preparation for cough, cold, fever and diarrhea of children, AYUSH-56-anti-epileptic preparation, AYUSH-SS granules -preparation to enhance the quality and quantity of breast milk in mother having deficient lactation, AYUSH AG tablet-preparation for ante natal care (anemia), AYUSH PK Avleha-preparation for post natal care (to enhance the process of recovery after delivery and other complications of puerperal period), AYUSH PG tablet-Preparation for ante natal care (edema), AYUSH BR leham-preparation for pediatric care are also developed (Table 1) .
Drug Development Studies in Progress
Central Council for Research in Ayurvedic Sci ences (CCRAS) has undertaken the development of the various coded formulations for different disease conditions
Mental Retardation/Cognitive Deficit
Central Council for Research in Ayurvedic Sci ences (CCRAS) has completed a multicentric clinical study for validation of a coded drug named AYUSH manas drug for mental retardation/cognitive deficit.
Cancer
Central Council for Research in Ayurvedic Sci ences (CCRAS) has undertaken work for developing a coded drug named AYUSH QOL 2C for improving quality of life in cancer patients (to prevent side effects of chemotherapy in stage III and IV nonsmall cell lung cancer and patients of local non-metastatic breast cancer, its clinical study has been completed successfully).
Geriatric health
Collaborative multicentric clinical trial to study the effect of AYUSH Rasayana (A and B) on ageing on apparently healthy elderly subjects is going on at AIIMS New Delhi, IMS BHU and CARIDD Kolkata.
Wound healing
Controlled clinical trial to assess the effectiveness of topical application of AYUSH C1 herbal oil on the superficial external wound and split-thickness skin graft donor's site for surgical wound healing at AIIMS New Delhi.
Dengue
Central Council for Research in Ayurvedic Sci ences (CCRAS) has undertaken a collaborative research work in collaboration with ICMR for the assessment of safety and efficacy of a coded drug AYUSH PJ-7 for the management of dengue Apart from these collaborative studies are going on for the development of coded drug for several disease of national importance including: AYUSH M-3 for migraine, AYUSH SL for filariasis, AYUSH A for bronchial asthma, AYUSH D for type II diabetes mellitus, Carctol S for ovarian cancer, AYUSH K1 for chronic kidney diseases, AYUSH GMH for fatty liver disease and AYUSH PTK for hepato-protection as adjuvant to anti tubercular treatment (ATT) have been taken up which are at different phases of drug development (Tables 2 to 4) .
CONCLUSION
Since ancient times, drugs have been an essential part of the therapeutic and preventive armamentarium. India has got huge traditional medicinal heritage in the world 
